CovInnovations
Early Stage
The new standard of COVID-19 solutions.
Overview
Raised: $3,784
Total Commitments ($USD)
Platform
StartEngine
Start Date
12/19/2022
Close Date
02/15/2023
Min. Goal
$15,000
Max. Goal
$1,234,986
Min. Investment
$244
Security Type
Equity - Common
Series
Seed
Funding Type
RegCF
Price Per Share
$7.40
Pre-Money Valuation
$49,980,000
Rolling Commitments ($USD)
Status
Active
Reporting Date
02/02/2023
Days Remaining
13
% of Min. Goal
25%
% of Max. Goal
0%
Likelihood of Max
Avg. Daily Raise
$84
# of Investors
6
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Location
Las Vegas, Nevada
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
CovInnovations, with a valuation of $10.01 million, is raising funds on Startengine. They are focused on discovering and developing groundbreaking technologies that assess, diagnose, and treat COVID-19. CovInnovations has developed a potential cure for hospitalized patients with severe COVID-19 in need of oxygen supplementation. The Company is in the pre-revenue stage of development. Dr. Aury Nagy, M.D. FAANS founded CovInnovations in May 2021. The current crowdfunding campaign has a minimum target of $15,000 and a maximum target of $1,234,998.96. The campaign proceeds will be used for research and development and working capital.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-831,753 |
$0 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$2,127 |
$0 |
|
Accounts Receivable |
$72,348 |
$0 |
|
Total Assets |
$74,476 |
$0 |
|
Short-Term Debt |
$296,233 |
$0 |
|
Long-Term Debt |
$609,996 |
$0 |
|
Total Liabilities |
$906,229 |
$0 |
Financials as of: 12/19/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
